Journal of Movement Disorders

Case Report

Treatment of Acute Delirium in a Patient with Parkinson’s Disease by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine: Morgan Lombardo, Amanda DiPiazza, Kelly Rippey, Naomi Lubarr, Elana Clar, Hooman Azmi; J Mov Disord. 2020;13(2):159-162. Published online May 29, 2020; DOI: https://doi.org/10.14802/jmd.20005

7,207 View
158 Download
3 Web of Science
3 Crossref

The treatment of delirium or psychosis in patients with Parkinson’s disease (PD) can be complicated by the limited number of pharmacological agents that can be used in this population. Typical and atypical antipsychotics are contraindicated, as they can worsen motor symptoms. The treatment of acute delirium is even more complicated in the hospital setting, as many medications deemed safer in this population are only available in oral form. We present a case of acute delirium in a patient with PD, likely precipitated by a polypharmacy interaction of new medications, that was successfully managed by transferring the patient to the intensive care unit and administering dexmedetomidine for 72 hours.

Citations

Citations to this article as recorded by

Toxin Induced Parkinsonism and Hospitalization Related Adverse Outcome Mitigation for Parkinson’s Disease: A Comprehensive Review
Kenneth R. Dalton, Charles J. Kidd, Nawaz Hack
Journal of Clinical Medicine.2023; 12(3): 1074. CrossRef
Fountain of youth—Targeting autophagy in aging
Lea Danics, Anna Anoir Abbas, Balázs Kis, Karolina Pircs
Frontiers in Aging Neuroscience.2023;[Epub] CrossRef
Effect of dexmedetomidine on postoperative delirium in patients undergoing brain tumour resections: study protocol of a randomised controlled trial
Dexiang Wang, Ruowen Li, Shu Li, Juan Wang, Min Zeng, Jia Dong, Xiaoyuan Liu, Nan Lin, Yuming Peng
BMJ Open.2021; 11(11): e051584. CrossRef

First
Prev
Page of 1
Next
Last

Search